BioCentury
ARTICLE | Clinical News

Dyloject diclofenac sodium regulatory update

January 19, 2015 8:00 AM UTC

FDA approved an NDA from Hospira for IV Dyloject diclofenac to manage moderate to severe pain alone or in combination with opioid analgesics and manage mild to moderate pain. Hospira gained the IV NSA...